Cargando…
Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients
Human epidermal growth factor receptor 2 (HER2/ERBB2) factor is known to be implicated in many malignancies and the potential of it as a prognostic biomarker was reported years ago. Molecular subtypes of HER2/ERBB2 negative and positive with distinct clinical outcomes have been identified in recent...
Autores principales: | Albarakati, Nada, Al-Ghamdi, Hanin, Al-Sowayan, Batla, Alshareeda, Alaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359419/ https://www.ncbi.nlm.nih.gov/pubmed/37474724 http://dx.doi.org/10.1038/s41598-023-38923-y |
Ejemplares similares
-
Preparing the Bone Tissue Regeneration Ground by Exosomes: From Diagnosis to Therapy
por: Al-Sowayan, Batla, et al.
Publicado: (2020) -
Interaction between HER2 and ATM predicts poor survival in bladder cancer patients
por: Albarakati, Nada, et al.
Publicado: (2022) -
Indistinguishable Landscapes of Meiotic DNA Breaks in rad50(+) and rad50S Strains of Fission Yeast Revealed by a Novel rad50(+) Recombination Intermediate
por: Hyppa, Randy W., et al.
Publicado: (2008) -
The Rad52 SSAP superfamily and new insight into homologous recombination
por: Al-Fatlawi, Ali, et al.
Publicado: (2023) -
Homologous recombination, cancer and the ‘RAD51 paradox’
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021)